血液学・フローサイトメトリーアナライザー及び試薬の日本市場2019-2023

◆英語タイトル:Japan Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities
◆商品コード:VPG906179
◆発行会社(リサーチ会社):Venture Planning Group
◆発行日:2019年6月
◆ページ数:250
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:日本
◆販売価格オプション(消費税別)
Local PDFUSD6,200 ⇒換算¥651,000見積依頼/購入/質問フォーム
Global PDFUSD9,700 ⇒換算¥1,018,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Venture Planning Group社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

LeadingMarketResearch.com’s new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese hematology and flow cytometry markets during the next five years.

The report explores business and technological trends in the Japanese market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

Japanese Market Overview

- Facilities performing hematology and flow cytometry testing.
- Test volume and sales projections.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Market Segmentation Analysis
- Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.
- Specimen, test and sales forecasts for over 40 procedures by individual test and market segment:
     – Hospitals
     – Commercial/Private Laboratories

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Current and Emerging Products

- Analysis of current and emerging hematology and flow cytometry assays.
- Reagent and instrument sales forecasts by market segment.
- Instrument placements and installed base by manufacturer and model.
- Sales and market shares of reagent and instrument suppliers.

Instrumentation Review

- The study reviews current instrumentation Technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.

- The report features analyzers manufactured by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.

Technology Review

- Assessment of current and emerging Technologies and their potential market applications.
- Comprehensive lists of companies developing or marketing new Technologies and products by test.

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.

- The companies analyzed in the report include:

Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens Healthineers
Sysmex

Contains 250 pages and 32 tables

【レポートの目次】

http://www.LeadingMarketResearch.com/pdffiles/LOTJapanHematologyandFlowCytometryMarketSalesForecastsupplierSharesCompetitiveStrategies.pdf

http://www.vpgcorp.com/webfiles/Hematology/HematologyCompanyProfiled.pdf

【掲載企業】

Competitive Assessments

- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血液学・フローサイトメトリーアナライザー及び試薬の日本市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆